Avricore Health Inc(AVCRF)
USD --+0.00%
Reward56Moderate
Risk26Low
📊75%Data
Thin -85% profit margin · Revenue down 97% YoY
AVCRF
+0.0 · +0.00%
USD · PINK
Avricore Health Inc | Healthcare
Quality Compounder
Market Cap:4.21M
ℹ️
Reward Rating
56
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
26
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on AVCRF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Avricore Health Inc?

engages in the health data and point-of-care technologies business.

AVCRF · Verdict

Solid reward · low risk

AVCRF stands out on volatility and balance sheet, but watch the profitability signal.

Based on 88% data coverage

AVCRF · Verdict

What’s working & what to watch

Strengths 3

  • Volatility95/100

    Top decile vs peers

  • Balance sheet86/100

    Current ratio 4.78

  • Growth68/100

    Rev +239.0% CAGR · earnings -27.4%

Watchouts 1

  • Profitability38/100

    -14% net margin · -86% ROE

Model-based scoring. For information only — not financial advice.

What is Avricore Health Inc?

engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 4.21M.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (56)

The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap4.21M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0787
52 Week Low0.0166
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding101M
No. of EmployeesN/A
IndustryDiagnostics & Research
ExchangePINK
Beta0.347
CurrencyUSD · Reports in CAD